Pittcon 2023 – Tuesday Networking Sessions
Pittcon’s networking sessions cover a range of techniques and topics. We had two afternoon networking sessions, from 2:00 to 3:30 pm, to recommend. One addressed the impact of automation and AI in the pharmaceutical R&D laboratory (room 202A). The other offered a forum to address the exchange of safety information concerning extractables and leachables (room 203A).
The session on extractables and leachables was hosted by James Vergis of the Enabling Technologies Consortium and Lee Nagao of Faegre Drinker Biddle and Reath, LLP. This forum will bring together analytical technology providers and industry members to discuss the current extractables and leachables landscape and collaboration opportunities. Topics that were discussed included regulatory guidance, data sharing, and leachables risk management.
The forum on automation and AI in the pharmaceutical industry was hosted by Michael Wleklinski of Merck. The group addressed how automation and new developments in artificial intelligence can efficiently impact drug candidate progression by using experimental data. Part of this session also addressed adopting artificial intelligence technologies into the laboratory, and what challenges and successes attendees have had in doing so.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
USP CEO Discusses Quality and Partnership in Pharma
December 11th 2024Ronald Piervincenzi, chief executive officer of the United States Pharmacoepia, focused on how collaboration and component quality can improve worldwide pharmaceutical production standards during a lecture at the Eastern Analytical Symposium (EAS) last month.
